LOBULAR BREAST CARCINOMA
Clinical trials for LOBULAR BREAST CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LOBULAR BREAST CARCINOMA trials appear
Sign up with your email to follow new studies for LOBULAR BREAST CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Lung cancer drug repurposed in fight against Hard-to-Treat breast and stomach cancers
Disease control CompletedThis study tested whether a drug called crizotinib, used for some lung cancers, could help control advanced lobular breast cancer and certain other hard-to-treat cancers. For breast cancer patients, it was combined with a hormone-blocking drug called fulvestrant. The main goal wa…
Matched conditions: LOBULAR BREAST CARCINOMA
Phase: PHASE2 • Sponsor: Royal Marsden NHS Foundation Trust • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Scientists hunt genetic clues to hereditary breast cancer
Knowledge-focused CompletedThis study aimed to understand how inherited changes in a gene called CDH1 affect a woman's risk of developing a specific type of breast cancer called lobular breast cancer. Researchers analyzed genetic data from 421 women who had early-onset or bilateral lobular breast cancer to…
Matched conditions: LOBULAR BREAST CARCINOMA
Sponsor: European Institute of Oncology • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:30 UTC